Military "anticipatory consent" for unapproved agents suggested by FDA in Federal Register notice.
MILITARY RECRUIT "ANTICIPATORY CONSENT" TO RECEIVE UNAPPROVED AGENTS is one possibility raised by FDA in a July 31 request for comments on military exemptions to informed consent procedures. "Instead of waiving the requirement for informed consent, is it feasible to obtain anticipatory consent from military recruits (prior to their recruitment into the military) for the future use of investigational products during a military conflict?" the agency asked. Alternatively, FDA suggested, "anticipatory consent" could be given during peace time. In either case, "would such consent be valid as `informed consent'? What would be the needed consent algorithm to make it valid and feasible?"
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth